Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 422 participants.
Also called NCT07314775
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 422 participants
- Sponsor
- Xinjiang Uygur Pharmaceutical Co., Ltd.
- Registry
-
NCT07314775
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07314775. Randomized; double masking; primary purpose treatment. Start 2026-01 (anticipated); primary completion 2028-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Yangxin Dawayimixike Honey Paste for Carotid Atherosclerotic Plaque With Dyslipidemia: A Randomized Controlled Clinical Study
- Condition
- Dyslipidemia
- Condition
- Carotid Atherosclerotic Plaques
- Intervention (Drug)
- Yangxin Dawayimixike Honey Paste
- Intervention (Drug)
- Yangxin Dawayimixike Honey Paste placebo
- Lead sponsor
- Xinjiang Uygur Pharmaceutical Co., Ltd.
Record details
- Record id
cardio:ct-nct07314775- Content hash
ac7a1b3ce98a0ee91eccfb69ef05e71ddb64de66ccc739329f50c70bb66a44d7